-0.310 (-0.31%)

Range 96.560 - 101.000   (4.60%)
Open 99.300
Previous Close 100.980
Buy Price 80.460
Buy Volume -
Sell Price 80.470
Sell Volume -
Volume 11,615,963
Value -
Measurement Type Value
EPS (USD) 3.454
Trailing EPS (USD) 3.964
NAV (USD) 38.64
Cash In Hand (USD) 2.766
Dividend 2.08
Dividend Yield (%) 2.06
PE 29.236
Trailing PE 25.474
Price / NAV 2.613
Price / Cash In Hand 36.504
Issued & Paid-up Shares 1,340,790,000
Treasury Shares -
Market Cap (M) 135,392.974
Par Value (USD) n.a.
Beta - 75 Days 0.584
R-Squared - 75 Days(%) 21.7
Beta - 500 Days 0.649
R-Squared - 500 Days(%) 19.47
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 29 Feb 2020 05:09.
Data powered by

Upcoming Events

* Stock event date based on US timezone.


Release Date: 21 May 2020
View All Events


Medtronic, Inc. (Medtronic) is a medical technology company. The Company provides products and therapies for use by medical professionals to meet the healthcare needs of their patients. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, and ear, nose, and throat and diabetes conditions. Medtronic operates through three segments that manufacture and sells device-based medical therapies. Its operating segments are Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM), Coronary, Structural Heart and Endovascular; Restorative Therapies Group, which consists of Spine, Neuromodulation and Surgical Technologies, and Diabetes Group. In January 2014, the Company acquired TYRX, Inc. In July 2014, it acquired Visualase, Inc. Effective August 27, 2014, the Company acquired the remaining 70% interest in NGC Medical SpA.

Loading Chart...

Target Price
Add Stop Loss
Time Frames
Share With: